Martin Murphy

Martin Murphy has an impressive background with extensive experience in various leadership roles in the healthcare and cancer research sectors.

He is currently the Co-founder & Chief Executive at Shanghai TuoXin Health Promotion Center, where he continues to drive initiatives and projects in the health promotion space.

Prior to his current role, Martin Murphy served as the Co-chairman of the Scientific Advisory Council at the International Alliance for Covid-19 Data Research at the renowned Bill & Melinda Gates Foundation.

His contributions extend to his role as the Convener & Co-chairman at the CSCO-STO Annual Symposia, showcasing his commitment to advancing oncology and translational research.

Martin Murphy's leadership skills were further recognized during his tenure as the Chairman Emeritus of the Board of Directors at the Conquer Cancer Foundation of ASCO.

He also played a key role as the Emeritus Member of the Board of Directors and Founding CEO at the CEO Roundtable on Cancer & Project Data Sphere, where he led impactful initiatives in the fight against cancer from 2000 to 2020.

Additionally, Martin Murphy co-founded and convened the Society for Translational Oncology and served as the Chairman & CEO at AlphaMed Consulting, displaying his diverse experience across the healthcare and consulting sectors.

His expertise further extends to the realm of academic publishing, as he was the Co-founder & Executive Editor of renowned peer-reviewed journals such as 'STEM CELLS,' 'STEM CELLS Translational Medicine,' and 'The Oncologist.'

Moreover, Martin Murphy's influence was felt in the international arena as he served as a Convener at the European Cancer Concord, showcasing his global perspective on cancer research and collaboration.

With a strong commitment to cancer advocacy and research, he also co-founded and served as the Founding Chief Executive Officer at CEO Roundtable on Cancer, highlighting his dedication to driving impactful change in the healthcare landscape.

Martin Murphy's illustrious career also saw him leading the CEO Roundtable on Cancer & Project Data Sphere® as its Chief Executive Officer, further solidifying his reputation as a prominent figure in the healthcare industry.